IMW 2019 | Off the shelf NK-cell MM therapy
Sarah Holstein
• 14 Sep 2019
Sarah Holstein, MD, PhD, University of Nebraska Medical Center, Omaha, NE, elaborates on placental derived natural killer (NK) cells (PNK007) and their integration into the post-melphalan transplantation period of multiple myeloma (MM). Dr Holstein goes on to lay out the next steps for PNK-cell therapy. This interview was recorded at the International Myeloma Workshop (IMW) 2019, held in Boston, MA.
